The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
sodium;(5R,6R)-3-tert-butyl-7-oxo-6-[[3-[(2-phenylacetyl)amino]propanoylamino]methyl]-4-oxa-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate ID: ALA74235
Max Phase: Preclinical
Molecular Formula: C22H26N3NaO6
Molecular Weight: 429.47
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: CC(C)(C)C1=C(C(=O)[O-])N2C(=O)[C@H](CNC(=O)CCNC(=O)Cc3ccccc3)[C@H]2O1.[Na+]
Standard InChI: InChI=1S/C22H27N3O6.Na/c1-22(2,3)18-17(21(29)30)25-19(28)14(20(25)31-18)12-24-15(26)9-10-23-16(27)11-13-7-5-4-6-8-13;/h4-8,14,20H,9-12H2,1-3H3,(H,23,27)(H,24,26)(H,29,30);/q;+1/p-1/t14-,20+;/m0./s1
Standard InChI Key: UUULFEZBHRPQFL-OWKALNPCSA-M
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 429.47Molecular Weight (Monoisotopic): 429.1900AlogP: 1.01#Rotatable Bonds: 8Polar Surface Area: 125.04Molecular Species: ACIDHBA: 5HBD: 3#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0CX Acidic pKa: 4.01CX Basic pKa: CX LogP: 0.31CX LogD: -2.84Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.53Np Likeness Score: -0.25
References 1. Wild H, Metzger K. (1993) Substituted 6-alkyloxapenems: potent -lactamase inhibitors: synthesis and biological characterization, 3 (11): [10.1016/S0960-894X(01)80926-4 ]